Pharmacology Review @pharmacologyreview · 6 years ago
pharmacologyreview.com
Atorvastatin. HMG-CoA reductase inhibitor (statin) for dyslipidemia and MI/stroke prevention. 2nd most prescribed drug in the
pharmacologyreview.com 
Atorvastatin. HMG-CoA reductase inhibitor (statin) for dyslipidemia and MI/stroke prevention. 2nd most prescribed drug in the US in 2017.

#Pharmacology #Atorvastatin #Lipitor #Statin #HMGCoAReductase #Overview #Review
Pharmacology Review @pharmacologyreview · 6 years ago
Clinical Pharmacology News and Education - https://twitter.com/thepharmareview
Related images